CN109303773A - A kind of postoperative wound care thimerosal - Google Patents
A kind of postoperative wound care thimerosal Download PDFInfo
- Publication number
- CN109303773A CN109303773A CN201810773690.2A CN201810773690A CN109303773A CN 109303773 A CN109303773 A CN 109303773A CN 201810773690 A CN201810773690 A CN 201810773690A CN 109303773 A CN109303773 A CN 109303773A
- Authority
- CN
- China
- Prior art keywords
- parts
- thimerosal
- wound
- wound care
- postoperative wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/345—Nitrofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of postoperative wound care thimerosal, by the material composition of following parts by weight, 5-10 parts of ethyl alcohol, 8-10 parts of tea polyphenols, 2-6 parts of carboxylic butyl chitosan, 10-20 parts of ascorbic acid, 1-2 parts of Phenoxyethanol, 4-6 parts of furacilin solution；It takes above-mentioned each component to be uniformly mixed, obtains this thimerosal.The present invention has the following technical effects by adopting the above technical scheme, can prevent wound infection, promotes wound healing, and analgesic is antipruritic.
Description
Technical field
The present invention relates to field of medical technology, and in particular to a kind of postoperative wound care thimerosal.
Background technique
Surgery cut infection is one of most common postoperative complication of surgery patients, and surgery cut infection is be easy to cause
Patient wound's poor healing extends the hospital stays, increases the pain and financial burden of patient, it is serious possibly even can be with next life
Critically ill danger.Clinically operative incision often is reduced in terms of sterile working, hand Postoperative Dressing this these three from Preoperative Method, operation
Infection rate.
Surgery cut infection is divided into pyogenic infection and specific infection, and pyogenic infection is special caused by general pyogenic baeceria
Opposite sex infection has special clinical characters caused by special germ.Principle of reatment is the cause of disease of infection to be eliminated, and removes purulence
Liquid and necrotic tissue increase the anti-infective and repair ability of patient.
The drug of existing clinical treatment surgical infection is mainly antibiotic medicine and Chinese medicine, takes antibiotic to dosage and treatment
Cheng Jun there are certain requirements, and Time of Administration is unsuitable too long, and effect is poor, toxic side effect is big, or even can not be restored.Existing treatment surgery
The traditional Chinese medicine ingredients of infection are complicated, it is slower to take effect, and effect is not obvious enough.
The patent of invention that number of patent application is 201210084084.2 discloses a kind of wound infection after surgical operation for the treatment of
Drug, including 40-60 parts of Radix Angelicae Sinensis 40- of ciliate desert-grass, 60 parts of elephant hides 30-50 parts of pearls of 20-45 parts of phoenix clothings
25-50 parts of blood of powder more than 15-30 portions of 35-55 parts of Radix Et Rhizoma Rheis, 30-50 parts of Radix Notoginseng of 15-30 portions of radix scrophulariae
10-20 parts 5-2 parts of borneol of 25 parts of myrrhs of red halloysite 15-.Above scheme has no toxic side effect, cheap, treatment
Speed is fast, and curative effect is reliable, and prescription linking closely corruption mentions poison, activating microcirculation and removing stasis medicinal, promoting granulation and wound healing, and sequelae is not stayed in blood-enrich.On but
It states drug and does not promote wound healing, relieve pain, antipruritic effect.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of postoperative wound care thimerosal, can prevent from hurting
Mouthfeel dye, promotes wound healing, and analgesic is antipruritic.
In order to solve the above technical problems, the present invention uses following technical scheme, a kind of postoperative wound care thimerosal is special
Sign is being: by the material composition of following parts by weight, 5-10 parts of ethyl alcohol, 8-10 parts of tea polyphenols, 2-6 parts of carboxylic butyl chitosan resists
Bad hematic acid 10-20 parts, 1-2 parts of Phenoxyethanol, 4-6 parts of furacilin solution；It takes above-mentioned each component to be uniformly mixed, obtains this disinfection
Liquid.
It is further improvement of the present invention below:
The nursing thimerosal, by the material composition of following parts by weight, 8 parts of ethyl alcohol, 9 parts of tea polyphenols, 5 parts of carboxylic butyl chitosan,
15 parts of ascorbic acid, 1.5 parts of Phenoxyethanol, 5 parts of furacilin solution.
The present invention has the following technical effects by adopting the above technical scheme, can prevent wound infection, promotes wound healing,
Analgesic, it is antipruritic.
Specific embodiment
Embodiment 1, a kind of postoperative wound care thimerosal, 5-10 parts of ethyl alcohol, 8-10 parts of tea polyphenols, carboxylic butyl chitosan
2-6 parts, 10-20 parts of ascorbic acid, 1-2 parts of Phenoxyethanol, 4-6 parts of furacilin solution.It takes above-mentioned each component to be uniformly mixed, obtains
This thimerosal.
Usage: going above-mentioned thimerosal wiping in wound, and three times, wiping can fully recover for 3 days for wiping daily.
In clinical observation, postoperative wound care thimerosal of the invention has more apparent effect for wound healing, can
Every bacterium, antibacterial promotion wound healing, but can prevent with wound adhesion, analgesic, it is antipruritic, use patient one after wound care liquid dressing
Reflection is caused to be comfortable on, without pain is small to wound stimulation, and clearly, surface of a wound exudate significantly reduces, and the surface of a wound does not give an offensive smell, gas
Taste faint scent.
Embodiment 2, a kind of postoperative wound care thimerosal, 8 parts of ethyl alcohol, 9 parts of tea polyphenols, 5 parts of carboxylic butyl chitosan is anti-bad
15 parts of hematic acid, 1.5 parts of Phenoxyethanol, 5 parts of furacilin solution.It takes above-mentioned each component to be uniformly mixed, obtains this thimerosal.
Usage: going above-mentioned thimerosal wiping in wound, and three times, wiping can fully recover for 3 days for wiping daily.
In clinical observation, postoperative wound care thimerosal of the invention has more apparent effect for wound healing, can
Every bacterium, antibacterial promotion wound healing, but can prevent with wound adhesion, analgesic, it is antipruritic, use patient one after wound care liquid dressing
Reflection is caused to be comfortable on, without pain is small to wound stimulation, and clearly, surface of a wound exudate significantly reduces, and the surface of a wound does not give an offensive smell, gas
Taste faint scent.
Embodiment 3, a kind of postoperative wound care thimerosal, 10 parts of ethyl alcohol, 10 parts of tea polyphenols, 6 parts of carboxylic butyl chitosan resists
20 parts of bad hematic acid, 2 parts of Phenoxyethanol, 6 parts of furacilin solution.It takes above-mentioned each component to be uniformly mixed, obtains this thimerosal.
Usage: going above-mentioned thimerosal wiping in wound, and three times, wiping can fully recover for 3 days for wiping daily.
In clinical observation, postoperative wound care thimerosal of the invention has more apparent effect for wound healing, can
Every bacterium, antibacterial promotion wound healing, but can prevent with wound adhesion, analgesic, it is antipruritic, use patient one after wound care liquid dressing
Reflection is caused to be comfortable on, without pain is small to wound stimulation, and clearly, surface of a wound exudate significantly reduces, and the surface of a wound does not give an offensive smell, gas
Taste faint scent.
Claims (2)
1. a kind of postoperative wound care thimerosal, feature are being: by the material composition of following parts by weight, 5-10 parts of ethyl alcohol,
8-10 parts of tea polyphenols, 2-6 parts of carboxylic butyl chitosan, 10-20 parts of ascorbic acid, 1-2 parts of Phenoxyethanol, furacilin solution 4-6
Part；It takes above-mentioned each component to be uniformly mixed, obtains this thimerosal.
2. postoperative wound care thimerosal according to claim 1, feature are being: the nursing
Thimerosal, by the material composition of following parts by weight, 8 parts of ethyl alcohol, 9 parts of tea polyphenols, 5 parts of carboxylic butyl chitosan, ascorbic acid
15 parts, 1.5 parts of Phenoxyethanol, 5 parts of furacilin solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810773690.2A CN109303773A (en) | 2018-07-15 | 2018-07-15 | A kind of postoperative wound care thimerosal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810773690.2A CN109303773A (en) | 2018-07-15 | 2018-07-15 | A kind of postoperative wound care thimerosal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109303773A true CN109303773A (en) | 2019-02-05 |
Family
ID=65226016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810773690.2A Pending CN109303773A (en) | 2018-07-15 | 2018-07-15 | A kind of postoperative wound care thimerosal |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109303773A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105287743A (en) * | 2015-11-09 | 2016-02-03 | 柳青青 | Sterilization disinfectant formula for nursing |
| CN106619708A (en) * | 2016-11-17 | 2017-05-10 | 郑州郑先医药科技有限公司 | Disinfectant for wound disinfection |
| CN107875146A (en) * | 2017-11-07 | 2018-04-06 | 颜强 | A kind of anti-inflammation medicament |
-
2018
- 2018-07-15 CN CN201810773690.2A patent/CN109303773A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105287743A (en) * | 2015-11-09 | 2016-02-03 | 柳青青 | Sterilization disinfectant formula for nursing |
| CN106619708A (en) * | 2016-11-17 | 2017-05-10 | 郑州郑先医药科技有限公司 | Disinfectant for wound disinfection |
| CN107875146A (en) * | 2017-11-07 | 2018-04-06 | 颜强 | A kind of anti-inflammation medicament |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
| CN101543565A (en) | Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same | |
| Ghafouri et al. | Is 1% povidone-iodine solution superior to normal saline for simple traumatic wound irrigation? | |
| CN105770275A (en) | Paste for removing blood stasis and necrotic and promoting granulation and paste preparation method | |
| CN101264196B (en) | Externally-applied medicinal composition for treating surgical wound and preparation of ointment thereof | |
| CN100540067C (en) | Sterilized magnesium sulfate dressing preparation | |
| CN102716281B (en) | Care solution for cleaning wounds after operation | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| CN103977194A (en) | Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot | |
| CN106377602A (en) | Dendrobium officinale composite disinfection powder, and preparation method and application method thereof | |
| CN109303773A (en) | A kind of postoperative wound care thimerosal | |
| CN100540011C (en) | Treatment dermatosis and the traumatic medicinal liquid of using | |
| CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
| CN1723937A (en) | Plaster contg. tuber of hyacinth bletilla for treating burns | |
| CN102293783B (en) | Traditional Chinese medicinal composition for treating bedsore | |
| CN101596242A (en) | Pure disinfection of Chinese drug treatment liquid | |
| CN1210000A (en) | Ointment for wounds and sores and preparation thereof | |
| Kirby | Quality of life, exudate management and the Biatain foam dressing range | |
| CN108635362A (en) | A kind of pharmaceutical composition for treating diabetes | |
| CN115068532B (en) | Medicine for treating forearm swelling after interventional operation and preparation process | |
| CN100356930C (en) | External-use powder for treating swelling anducler and actue-chronic osteomyelitis | |
| CN1243553C (en) | External use medicine for hemostatic and trauma healing and promoting reunion of fractured bones | |
| CN1141967C (en) | Externally applied Chinese medicine oil prepn for treating burns and scalds | |
| CN1171626C (en) | External treatment powder for piles | |
| CN1319408A (en) | Medicated liquor for treating traumatic injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190205 |